Learning Objectives
Upon completion of this activity, participants should be able to:
- Integrate advances in diagnostic evaluation and therapeutics to treat patients with carotid and peripheral arterial disease
- Employ new interventional technologies, drugs and procedures into the care of patients with complex coronary and endovascular disease
- Discuss which stroke patients are candidates for thrombolytic therapy, and identify those who should receive endovascular thrombectomy
- Appraise percutaneous devices from concept through preclinical and clinical investigation. regulatory approval and clinical application for the treatment of structural heart and valve disease
- Outline clinical and social determinants that contribute to racial/gender disparities in cardiovascular disease and employ strategies to factor these inequalities into care
Target Audience
Interventional cardiologists, clinical cardiologists, cardiac surgeons, fellows, emergency medicine physicians, vascular surgeons, primary care physicians, basic scientists, radiologists, interventional radiologists, nurses, technologists, industry professionals, and other health care professionals who want to enhance their knowledge of complex coronary interventions and the treatment of patients with cardiovascular disease.
CME Information
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation
This activity is approved for AMA PRA Category 1 Credits™.
Successful completion of this CME activity enables the participant to earn MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.
ACHL will begin submitting MOC points starting April 1, 2022, and the 1st of the month after that through December 31. MOC points MUST be claimed by December 31, 2022. By providing your ABIM number, you consent to have ACHL and/or our educational partners submit your participation in this activity to the ABIM through the ACCME PARS system.
Disclosure of Financial Relationships With Any Commercial Interest
Guidelines require that participants in CME/CE activities be made aware of all financial relationships that may be perceived as affecting the presentation of the faculty member. ACHL ensures that all faculty and staff involved in the planning, development, and implementation of ACHL activities disclose relevant financial relationships and that conflicts of interest are mitigated before the CME/CE activity occurs.
PLEASE VISIT THE CONFERENCE MOBILE APP FOR A COMPLETE LIST OF FINANCIAL DISCLOSURES.
Staff/Reviewer Disclosure:
ACHL and MedStar Washington Hospital staff members/reviewers involved with the planning, development, and/or review of the content for this activity have no relevant affiliations or financial relationships to disclose.
Complete information will be provided to participants prior to the start of the educational activity.
For Nurses
For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credits™ issued by organizations accredited by the ACCME. Nurses who attend an activity certified for Category 1 credit can complete the continuing education hours section of the ANCC Professional Development Record in order to document the courses attended and the hours obtained.
For Radiologic Technologists
CARDIOVASCULAR PROFESSIONALS' SYMPOSIUM FOR NURSES AND TECHNOLOGISTS / WOMEN & HEART DISEASE LUNCHEON SYMPOSIUM: THIS ACTIVITY WILL OFFER Category A+ continuing education credits.